Table 2 Percentiles (%) of women exhibiting different lignans, average concentrations and concentration range (ng/ml) of individual lignans in the control and intervention groups at the baseline and at the end of intervention.
From: Effect of dietary intervention on serum lignan levels in pregnant women - a controlled trial
Baseline (gestational week 8 or 9) | End (gestational week 36 or 37) | |||||
|---|---|---|---|---|---|---|
Control* | Detected in number (%) of samples | Mean ng/ml (SD) | Range (nd = not detected) | Positive samples | Mean ng/ml (SD) | Range |
ENL | 53 | 0.46 (0.68) | nd-4.4 | 52 | 0.48 (0.38) | 0.03-2.4 |
HENL | 14 | 0.03 (0.024) | nd-0.09 | 17 | 0.02 (0.05) | 0-0.18 |
SECO | 4 | 0.22 (0.077) | 0.15-0.33 | 12 | 0.12 (0.09) | 0-0.3 |
MR | 39 | 0.003 (0.01) | nd-0.07 | 49 | 0.003 (0.01) | 0-0.05 |
END | 28 | 0.22 (0.34) | nd-1.8 | 32 | 0.22 (0.31) | 0-1.45 |
LAR | 9 | 0.14 (0.1) | nd-0.29 | 3 | 0.01 (0.02) | 0-0.04 |
CLAR | 10 | 0.13 (0.23) | nd-0.58 | 15 | 0.14 (0.12) | 0-0.43 |
PINO | 1 | 0.58 (0) | 0.58-0.58 | 4 | 0.25 (0.27) | 0-0.61 |
Sum of all lignans | 56 | 0.63 (0.82) | nd-4.61 | 56 | 0.66 (0.65) | 0-3.48 |
Intervention* | ||||||
ENL | 49 | 0.34 (0.39) | nd-2.2 | 49 | 0.85 (1.4) | 0.09-7.4 |
HENL | 10 | 0.03 (0.02) | nd-0.064 | 15 | 0 | 0 |
SECO | 2 | 0.10 (0.09) | 0.04-0.17 | 10 | 0.16 (0.15) | 0.015-0.5 |
MR | 33 | 0.004 (0.02) | nd-0.13 | 45 | 0.004 (0.01) | 0-0.07 |
END | 32 | 0.12 (0.12) | nd-0.33 | 32 | 0.19 (0.20) | 0-0.82 |
LAR | 7 | 0.03 (0.05) | nd-0.11 | 2 | 0.05 (0.07) | 0-0.1 |
CLAR | 9 | 0.10 (0.16) | nd-0.48 | 9 | 0.04 (0.07) | 0-0.2 |
PINO | 3 | 0.58 (0.26) | 0.30-0.81 | 4 | 0.21 (0.15) | 0-0.33 |
Sum of all lignans | 49 | 0.49(0.48) | 0.01-2.25 | 49 | 1.03 (1.56) | 0.14-8.16 |